Assenagon Asset Management’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,037,736
| Closed | -$4.26M | – | 1588 |
|
|
2022
Q1 | $4.26M | Buy |
1,037,736
+785,443
| +311% | +$3.22M | 0.01% | 539 |
|
|
2021
Q4 | $901K | Sell |
252,293
-907,153
| -78% | -$3.24M | ﹤0.01% | 1017 |
|
|
2021
Q3 | $4.22M | Sell |
1,159,446
-71,515
| -6% | -$260K | 0.01% | 450 |
|
|
2021
Q2 | $5.37M | Buy |
1,230,961
+575,910
| +88% | +$2.51M | 0.02% | 436 |
|
|
2021
Q1 | $2.69M | Buy |
655,051
+336,788
| +106% | +$1.38M | 0.01% | 618 |
|
|
2020
Q4 | $1.27M | Sell |
318,263
-206,302
| -39% | -$823K | 0.01% | 620 |
|
|
2020
Q3 | $1.42M | Buy |
524,565
+70,795
| +16% | +$191K | 0.01% | 640 |
|
|
2020
Q2 | $1.25M | Buy |
453,770
+430,360
| +1,838% | +$1.18M | 0.01% | 711 |
|
|
2020
Q1 | $55K | Buy |
+23,410
| New | +$55K | ﹤0.01% | 705 |
|